Alto Neuroscience, Inc (ANRO) insider trading
Every open-market stock purchase and sale by Alto Neuroscience, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Adam Savitz (C-suite exec), $38.7K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent ANRO insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| May 27, 2026 | Andrew Craig Miller (Director) | Bought (not open market) | — |
| May 14, 2026 | Amit Etkin (CEO) | Sold (not open market) | — |
| May 12, 2026 | Husseini Manji (Director) | Bought (not open market) | — |
| May 12, 2026 | Gwill York (Director) | Bought (not open market) | — |
| May 12, 2026 | Christopher Nixon Cox (Director) | Bought (not open market) | — |
| May 12, 2026 | Andrew Dreyfus (Director) | Bought (not open market) | — |
| May 12, 2026 | Ramiro Sanchez (Director) | Bought (not open market) | — |
| Mar 1, 2026 | Amit Etkin (CEO) | Sold (not open market) | $123K |
| Mar 1, 2026 | Nicholas Conrad Smith (CFO) | Sold (not open market) | $55.3K |
| Feb 11, 2026 | Michael Conick Hanley Jr. (COO) | Bought (not open market) | — |
| Feb 11, 2026 | Amit Etkin (CEO) | Bought (not open market) | — |
| Feb 11, 2026 | Nicholas Conrad Smith (CFO) | Bought (not open market) | — |
| Feb 11, 2026 | Adam Savitz (C-suite exec) | Bought (not open market) | — |
| Jan 2, 2026 | Christopher Nixon Cox (Director) | Bought (not open market) | $85K |
| Jan 2, 2026 | Gwill York (Director) | Bought (not open market) | $62K |
| Jan 2, 2026 | Husseini Manji (Director) | Bought (not open market) | $50K |
| Jan 2, 2026 | Ramiro Sanchez (Director) | Bought (not open market) | $45K |
Who's trading ANRO
- Andrew Craig Miller, Director: other filings, last May 27, 2026
- Amit Etkin, CEO: other filings, last May 14, 2026
- Andrew Dreyfus, Director: other filings, last May 12, 2026
- Gwill York, Director: other filings, last May 12, 2026
- Christopher Nixon Cox, Insider: other filings, last May 12, 2026
- Husseini Manji, Director: other filings, last May 12, 2026
- Ramiro Sanchez, Director: other filings, last May 12, 2026
- Nicholas Conrad Smith, CFO: other filings, last Mar 1, 2026
- Adam Savitz, C-suite exec: other filings, last Feb 11, 2026
- Michael Conick Hanley Jr., COO: other filings, last Feb 11, 2026
Get free alerts when an insider at Alto Neuroscience, Inc files a new trade →